Authors :
Pooja Yadav; Devashish Jena; Priya Pal
Volume/Issue :
Volume 10 - 2025, Issue 4 - April
Google Scholar :
https://tinyurl.com/ms2dv7jp
DOI :
https://doi.org/10.38124/ijisrt/25apr2145
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Global Issues in Pharmaceutical Marketing offers a balanced, research-oriented point of view and a practical
approach towards today's issues confronting the ethical, biotech, and generic pharmaceutical industry segments. It brings
an analytical thinking and a global perspective to wards analyzing issues like market access, e- marketing, emerging
markets, branding, and soon. The book addresses not only the North American and Western European markets but non-
Western markets, like Latin America and Asia. The chapters are all written as independent essays on a particular issue,
and where applicable, new cases are presented to show how the issues are handled by the world industry today.
Keywords :
Drug Pricing Access to Medicine Pharmaceutical Ethics Direct-to-Consumer Advertising(DTCA) Patent Protection Generic Drugs Big Pharma Regulatory Compliance Clinical Trial Transparency off -Label Marketing Pharmaceutical Lobbying Counter Feit Drugs Health Equity Marketing in Low-Income Countries Influence on Health Care Professionals.
References :
- KatsanisLP.Globalissuesinpharmaceuticalmarketing.Routledge;2015Jul16.
- Limbu, Yam B., and Bruce A. Huhmann. "Ethical issues in pharmaceutical marketing: A systematic review and future research agenda."Journal of Global Marketing 35.1 (2022): 1-20
- Pitta,Dennis. "GlobalIssues inPharmaceuticalMarketing."InternationalJournal of Pharmaceutical and Healthcare Marketing 10, no. 2 (2016):
- Rajput K, Pandey RK. Pharmaceutical marketing: A literature review. International Journal of Eng
- Narayana, S.A., Pati, R.K. and Vrat, P., 2012. Research on management issues in the pharmaceutical industry: a literature review. International Journal of Pharmaceutical and Healthcare Marketing, 6(4), pp.351-375.ineering and Management Research. 2022;12(2):56-63.30-231.
- MasoodI, Ibrahim M, HassaliM, Ahmed M. Evolution of marketing techniques, adoption in pharmaceutical industry and related issues: a review. Journal of Clinical and Diagnostic Research. 2009 Dec 1;3(6
- Mackey TK, Liang BA. Pharmaceutical digital marketing and governance: illicit actors and challenges to globalpatient safetyand public health. Globalizationand health. 2013 Dec;9:1-2.):1942-52.
- Holland,S.andBátiz-Lazo,B.,2004.Theglobalpharmaceutical industry. General Economics and Teachin
- Petryna A, Kleinman A, Lakoff A, editors. Global pharmaceuticals: Ethics, markets, praAkhtarG.Indianpharmaceut icalindustry:anoverview.IOSR journal of Humanities and Social Science. 2013 Jul;13(3):51-66.ctices. Duke University Press; 2
- Rollins BL, Perri M. Pharmaceutical marketing. Jones & Bartlett Publishers; 2014.006 Mar 15.g, 405002, pp.1-24.
- Ahmed R, Sattar I, Vishnu P. Product strategies in pharmaceutical marketing: a perspective of Pakistani pharmaceutical industry. Middle-East Journal of Scientific Research. 2014 May 17;21(4):681-8.
- Akhtar G. Indian pharmaceutical industry: an overview. IOSR journal of Humanities and Social Science. 2013 Jul;13(3)
- Tannoury M, Attieh Z. The influence of emerging markets onthe pharmaceutical industry. Current therapeutic research. 2017 Jan 1;86:19-22.:51-66.
- Shaw, B. and Whitney, P., 2016.Ethicsand compliance inglobalpharmaceutical industrymarketingandpromotion: TheroleoftheIFPMAandself- regulation. Pharmaceuticals Policy and Law, 18(1-4), pp.199-206.
- Saha, C.N. and Bhattacharya, S., 2011. Intellectual property rights: An overview and implications inpharmaceuticalindustry. Journalof advancedpharmaceutical technology & research, 2(2), pp.88-93.
- Ponce MF. AnOverview ofthe GlobalPharma Industry’s New Trends. Availableat SSRN 3397618. 2019 Jun 1
- Tukdeo R, Kalilombe E, Onyeugbo OC, Okafor F, Ebeleghe R. The global pharmaceutical industry..
- Piachaud B. An Overview of the GlobalPharmaceutical Industry. Outsourcing of R&D in the Pharmaceutical Industry: From Conceptualisation to Implementation of the Strategic Sourcing Process. 2004:5-33.
- Horrobin DF. Innovation in the pharmaceutical industry. Journal of the Royal Society of Medicine. 2000 Jul;93(7):341-5.
- Achilladelis B, Antonakis N. The dynamics of technological innovation: the case of the pharmaceutical industry. Research policy. 2001 Apr
- Jungmittag, A., Reger, G. and Reiss, T. eds., 2013. Changing innovation in the pharmaceutical industry: globalization and new ways of drug development. Springer Science & Business Media.1;30(4):535-88.
- Gassmann O, Reepmeyer G, Von Zedtwitz M. Leading pharmaceutical innovation. Berlin: Springer. https://doi. org/10. 2008;1007:978-3.
- Alexander DL, Flynn JE, Linkins LA. Innovation, R&D productivity, and global market share in the pharmaceutical industry. Review of Industrial Organization. 1995 Apr;10:197-207.
- Petrova E. Innovation in the pharmaceutical industry: The process of drug discoveryanddevelopment.InInnovationandMarketinginthePharmaceutical
- Industry: Emerging Practices, Research, and Policies 2013 Oct 26 (pp. 19-81). New York, NY: Springer New York.
- Bowonder B, Thomas MT, RokkamVM, Rokkam A. The global pharmaceutical industry: changing competitive
- Sadat, T., Russell, R. and Stewart, M., 2014. Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry. International Journal of Knowledge, Innovation and Entrepreneurship, 2(1), pp.6-31. landscape. International Journal of Technology Management. 2003 Jan 1;25(3- 4):201-26.
Global Issues in Pharmaceutical Marketing offers a balanced, research-oriented point of view and a practical
approach towards today's issues confronting the ethical, biotech, and generic pharmaceutical industry segments. It brings
an analytical thinking and a global perspective to wards analyzing issues like market access, e- marketing, emerging
markets, branding, and soon. The book addresses not only the North American and Western European markets but non-
Western markets, like Latin America and Asia. The chapters are all written as independent essays on a particular issue,
and where applicable, new cases are presented to show how the issues are handled by the world industry today.
Keywords :
Drug Pricing Access to Medicine Pharmaceutical Ethics Direct-to-Consumer Advertising(DTCA) Patent Protection Generic Drugs Big Pharma Regulatory Compliance Clinical Trial Transparency off -Label Marketing Pharmaceutical Lobbying Counter Feit Drugs Health Equity Marketing in Low-Income Countries Influence on Health Care Professionals.